BKBahar Kulu

Bahar Kulu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bahar Kulu has a total of 141 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Clinical spectrum and genetic landscape of MTHFR deficiency: a cohort study including novel variants

    by Karalar Pekuz, Ozge Kamer, Pelin Teke Kisa, Sevil Yildiz, Mehmet Kocabey, Tanyel Zubarioglu, Zumrut Arslan Gulten, Emine Sedef Sezen, Esra Er, Serdar Pekuz, et al.

  • Dietary supplement practices in children with inherited metabolic disorders receiving protein-restricted diets

    by Bahar Kulu, Özge Kamer Karalar Pekuz, Merve Bilen, Duygu Uzun Dinçtürk, Emine Didem Demirdöken, Pelin Teke Kısa, Nur Arslan

  • Association between plasma homocysteine levels and P-wave dispersion in pediatric patients with hyperhomocysteinemia

    by Bahar Kulu, Onur Taşçı, Haşim Olgun, Nuriye Ece Mintaş, Sibel Burçak Şahin Uyar, Zümrüt Arslan Gülten, Cüneyt Zihni, Sibel Büyükçoban, Volkan Hancı, Nur Arslan

  • Evaluation of Nutritional Habits and Quality of Life of Mothers of Children With Metabolic Diseases Requiring a Restricted Diet

    by Bereket Bağcı, Bahar Kulu, İdil Akay Hacı, Murat Bektaş, Sibel Burçak Şahin Uyar, Nuriye Ece Mintaş, Nur Arslan

    Restricted diet therapy is the cornerstone of treatment in many hereditary metabolic disorders. This study evaluated the effects of dietary treatments for affected children on the dietary habits, lifestyle, quality of life, and stress levels of their mothers. The study included 50 mothers of children aged 2 to 18 years with phenylketonuria, organic acidemias, urea cycle defects, or galactosemia, and 32 mothers of healthy children. Mothers completed a demographic and lifestyle questionnaire, the Short Form-36 Quality-of-Life questionnaire, and the Perceived Stress Scale. More than half of the mothers in the patient group reported modifying their own diets to align with their child’s restrictions, while some adopted vegetarian or vegan diets. Many reported limiting social activities, and 18% had quit their jobs to manage dietary treatment. Mothers of affected children showed significantly higher stress scores and lower quality-of-life scores than controls.

  • Open Access

    Seizure-Free Childhood-Onset GLUT1 Deficiency Presenting with Cognitive and Handwriting Regression

    by Bahar Kulu, Gizem Doğan, Gamze Sarikaya Uzan

    An abstract is unavailable. This article is available as a PDF only.

  • Open Access

    Evaluating the quality and reliability of YouTube videos about phenylketonuria

    by Bahar Kulu, Sibel Burçak Şahin Uyar, Batuhan Kulu, Volkan Hanci

    Phenylketonuria (PKU) is a congenital metabolic disorder characterized by defective phenylalanine metabolism, leading to neurotoxicity when untreated. Early detection through newborn screening and timely dietary intervention can ensure normal intellectual development. YouTube is a widely used source for health-related content, but the quality of information remains variable. The objective of this study is to evaluate the quality and reliability of YouTube videos related to PKU using validated scoring tools. This cross-sectional study was conducted on December 30, 2024. A YouTube search using the keyword “phenylketonuria” yielded 150 videos, of which 104 met the inclusion criteria. Video parameters including number of views, likes, duration, and content type were collected. Reliability was assessed using the Journal of the American Medical Association Benchmark Criteria and the modified DISCERN questionnaire. Quality and accuracy were evaluated using the Global Quality Score. Statistical analyses were performed to determine the relationships between video characteristics and evaluation scores. Of the analyzed videos, 45% were animated and 68% were uploaded by healthcare professionals. The median number of views was 1064 (range: 12–806,000) and the median view ratio was 0.68 (range: 0–245.36). Significant associations were found between the year of upload and view ratio ( P = .012), and between continent and both view ratio ( P = .045) and daily views ( P = .003). Likes-per-view differed significantly by country ( P < .001). According to the Global Quality Score, 56% of videos were of medium quality, with the highest scores observed in videos from professional organizations and academic sources. Journal of the American Medical Association assessment showed that 58.3% of videos contained sufficient information. Modified DISCERN questionnaire revealed that 46.6% of videos had poor reliability. The majority of PKU-related YouTube videos analyzed were of low to moderate quality and reliability. Given the impact of such content on patient decision-making, healthcare authorities should take an active role in producing and promoting high-quality digital health content.


  • Çocukluk Çağı Lökodistrofileri ve Görüntüleme Bulguları

    by Bahar Kulu, Özge Kamer Karalar Pekuz, Zehra Filiz Karaman, Nur Arslan

  • Open Access

    Canpolat&Karaman&Kardaş - Temel Pediatrik Nöroradyoloji Nörometabolik ve Heredodejeneratif Hastalıklarda Klinik ve Radyolojik Yaklaşım

    by Niyazi Acer, Özge Coşkun Sağlam, Hatice Yenigül, Cansu Kibar Karagöz, Şadan Tutuş, Hüseyin Tan, Aziz Anıl Tan, Özlem Özkale Yavuz, Ezgi Çağlar, Barış Ten, et al.

  • Open Access

    Retrospective Evaluation of Diet Compliance on Plasma Amino Acid and Vitamin Levels in Patients with Phenylketonuria

    by Buse Aytop Kol, Özlenen Şimşek Papur, Bahar Kulu, Nur Arslan

    Purpose: In this study, it was aimed to compare the plasma amino acid and blood vitamin/mineral levels in patients with classical phenylketonuria and healthy controls. Material and Methods: 54 patients with classical phenylketonuria and 22 healthy controls (76 children, 47 boys, 61.8%) were included in the study. The patient group was divided into two subgroups as high adherence to phenylalanine-restricted diet (HAD, 16 patients) and low adherence to this diet (LAD, 38 patients) according to the mean plasma phenylalanine level of the patients of the previous year. Anthropometric measurements (body weight and height and standard deviation score values), plasma phenylalanine and other amino acid levels, hemoglobin, vitamin B12, folic acid, vitamin D, zinc, ferritin levels of all groups were recorded. Results: The mean age of the entire study group was 10.1 ± 3.6 (minimum: 3.5 - maximum: 17) years. There was no significant difference between the phenylketonuria group and the control group in terms of age, gender distribution and anthropometric data. There was a significant difference between the three groups in terms of plasma phenylalanine levels (plasma phenylalanine levels 299.0 ± 77.2; 813.7 ± 356.6 and 47.5 ± 15.9 µmol/L in HAD, LAD and control groups respectively, p= 0.001). Tryptophan was significantly lower in the HAD group than in the LAD and control groups (p= 0.001 and p= 0.006, respectively). Lysine was found to be significantly higher and histidine was lower in the HAD group than the control group (p= 0.016 and p= 0.008, respectively). Hemoglobin, vitamin B12, folic acid and 25-OH vitamin D levels were found to be significantly higher in the PKU patient group compared to healthy children and no difference between zinc and ferritin levels. Conclusion: As a result, in patients with phenylketonuria who comply with the diet and whose anthropometric data are in the normal range, no significant deterioration in vitamin/mineral and amino acid values is observed. Compliance of the patients with a diet restricted from phenylalanine will both reduce the neurological effects and ensure that the patient is nutritionally balanced.


  • Ketogenic Diet in Niemann‐Pick Type C: Insights From a Case Report

    by Bahar Kulu, Pelin Teke Kısa, Esra Er, Serdar Pekuz, Zeynep Akisin, Serdar Ceylaner, Nur Arslan

    Niemann‐Pick disease type C (NPC) is a lysosomal storage disorder characterized by progressive neurological deterioration. Although there is no curative treatment, early initiation of miglustat, prior to significant neurological decline, may slow disease progression. This case report describes a patient whose initial symptoms emerged around age 9 and who was diagnosed with NPC at age 14 following gradual neurological decline. Despite being treated with miglustat, the patient's neurological symptoms worsened significantly. A high‐ratio ketogenic diet (KD), based on fat to protein plus carbohydrate, was initiated as an adjunctive therapy. Following dietary modification, neurological findings stabilized. An initially abnormal electroencephalogram (EEG) normalized during follow‐up. Due to significant weight loss, financial constraints and adherence difficulties, the KD ratio was reduced to 1:1 by the sixth month. At the time of the last evaluation, the patient had been maintained on the low‐ratio KD for 4 years with continued adherence. The ketogenic diet is known to offer therapeutic benefits in various neurological disorders. In NPC patients treated with miglustat—particularly those experiencing seizures—a ketogenic diet may support neurological stabilization. A lower ratio KD may enhance long‐term compliance.